Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-005738
Filing Date
2017-03-31
Accepted
2017-03-31 10:06:15
Documents
94
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apvo-10k_20161231.htm 10-K 2732293
2 EX-23.1 apvo-ex231_442.htm EX-23.1 3284
3 EX-31.1 apvo-ex311_441.htm EX-31.1 13187
4 EX-31.2 apvo-ex312_440.htm EX-31.2 13344
5 EX-32.1 apvo-ex321_439.htm EX-32.1 9326
6 EX-32.2 apvo-ex322_438.htm EX-32.2 9601
7 GRAPHIC g2017033113331338356260.jpg GRAPHIC 36885
  Complete submission text file 0001564590-17-005738.txt   9862177

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT apvo-20161231.xml EX-101.INS 2086495
9 XBRL TAXONOMY EXTENSION SCHEMA apvo-20161231.xsd EX-101.SCH 73011
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20161231_cal.xml EX-101.CAL 66225
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20161231_def.xml EX-101.DEF 233166
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20161231_lab.xml EX-101.LAB 506020
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20161231_pre.xml EX-101.PRE 429013
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37746 | Film No.: 17728411
SIC: 2834 Pharmaceutical Preparations